Value Chain Analysis on Cardiovascular Drugs Market | Global/ worldwide Market Size, share

The global cardiovascular drugs market size is set to touch USD 63.96 billion by 2026, exhibiting a CAGR of 3.8% during the forecast period. Increasing incidence of cardiovascular disorders will be one of the central driving forces of growth for this market in the next decade. According to the Global Burden of Disease Study 2017, cardiovascular disorder (CVD) is the most common chronic disease, killing around 17.8 million people annually. Of these, close to 82% of the deaths occur in low and middle-income countries. The World Health Organization (WHO) estimates that 80% of CVD deaths are caused by heart attack and strokes. These diseases also carry a heavy economic burden. For example, the American Heart Association estimates that by 2035, medical costs associated with CVD will hit USD 749 billion. Thus, there is a grave need to find effective medication to treat these conditions, augmenting the cardiovascular drugs market growth.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/cardiovascular-therapeutics-market-100379

Leading Players operating in the cardiovascular drugs market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

o Merck & Co., Inc.
o Pfizer Inc.
o F. Hoffmann-La Roche Ltd.
o Janssen Pharmaceuticals, Inc.
o Bristol-Myers Squibb Company
o Bayer AG
o Novartis AG
o Gilead Sciences, Inc.

Fortune Business Insights, through its report, titled "Cardiovascular Drugs Market Size, Share & Industry Analysis, By Drug Type (Antihypertensive, Antihyperlipidemic, Anticoagulants, Antiplatelet Drugs, Others), By Disease Indication (Hypertension, Hyperlipidemia, Coronary Artery Disease, Arrhythmia, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019 -2026", brings out a comprehensive analysis of the factors and dynamics that are likely to influence the share, size, and overall growth of the market during the forecast period. The report also provides a thorough research into the general industry trends that will enable competitors in this market to take well-informed business decisions.

Detailed Table of Content:

1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Prevalence of Major Cardiovascular Diseases by Key Countries
4.2. Pipeline Analysis
4.3. Key Industry Developments Such as Mergers & Acquisitions
4.4. New Product Launches
4.5. The Regulatory Scenario in Key Countries
4.6. Reimbursement Scenario by Key Countries
4.7. Advances in R&D for Novel Therapeutics
5. Global Cardiovascular Drugs Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast - By Drug Type
5.2.1. Antihypertensive
5.2.2. Antihyperlipidemic
5.2.3. Anticoagulants
5.2.4. Antiplatelet Drugs
5.2.5. Others
5.3. Market Analysis, Insights and Forecast - By Disease Indication
5.3.1. Hypertension
5.3.2. Hyperlipidemia
5.3.3. Coronary Artery Disease
5.3.4. Arrhythmia
5.3.5. Others
5.4. Market Analysis, Insights and Forecast - By Distribution Channel
5.4.1. Hospital Pharmacies
5.4.2. Retail Pharmacies
5.4.3. Online Pharmacies
5.4.4. Others
5.5. Market Analysis, Insights and Forecast - By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
6. North America Cardiovascular Drugs Market Analysis, Insights and Forecast, 2015-2026
TOC Continued...!

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.